Fri Aug 01 20:40:00 UTC 2025: Here’s a news article summarizing and rewriting the provided text:
**FDA Sounds Alarm on Potent Kratom Derivative, 7-OH, Amid Calls for Stricter Regulation**
**WASHINGTON, D.C. (Gray DC) -** The Food and Drug Administration (FDA) is raising serious concerns about the growing availability of 7-hydroxymitragynine (7-OH), a concentrated derivative of kratom that the agency warns is 13 times more potent than morphine. This substance, readily available in corner stores, smoke shops, and gas stations nationwide, is sparking fears of a new wave in the opioid crisis.
7-OH, often found in gummies, “shots,” tablets, and drinks, is a synthetic byproduct of kratom, a leaf commonly consumed in powdered form as a stimulant. FDA Commissioner Dr. Marty Makary emphasizes that 7-OH shares the same chemical properties as some of the most dangerous opioids, scientifically classifying it as such.
The ease of access to 7-OH has prompted HHS Secretary Robert F. Kennedy, Jr. to advocate for its classification as a Class 1 Controlled Substance, placing it in the same category as drugs like LSD and heroin. Kennedy, drawing from his personal experience with addiction, expressed concern that the widespread availability makes the substance far too easily accessible.
Senator Markwayne Mullin (R-OK) has also voiced strong concerns, stating that the drug is an addiction that is ruining lives.
In response, the FDA has begun taking action, issuing warning letters to companies marketing 7-OH products. The agency is collaborating with the Drug Enforcement Administration (DEA) to reclassify the substance as an illicit drug. The FDA aims to proactively address the issue and educate the public before the situation escalates further.
“This may be the calm before the storm,” warned Dr. Makary, urging aggressive and proactive measures to prevent a potential crisis. The FDA provides additional information on 7-OH on its website.
Copyright 2025 Gray DC. All rights reserved.
First Piper 